InvestorsHub Logo
Replies to #99113 on Biotech Values

DewDiligence

07/20/10 12:45 PM

#99114 RE: genisi #99113

…I think Isentress might be less of a competitor due to low barrier to resistance.

Also, Isentress requires BID dosing (at least for the time being). This is the main reason I dismissed Isentress so readily in #msg-50277627.